FOX04

Senolytic peptide selectively clearing senescent cells. At the forefront of longevity and anti-inflammatory science.

FOX04

2026-09-06

Product Brief

FOX04-DRI is a breakthrough senolytic peptide that selectively clears senescent cells — a key driver of aging and chronic inflammation. At the forefront of longevity science.

FOX04-DRI disrupts the interaction between FOXO4 and p53 in senescent cells, triggering selective clearance of aging cells that drive chronic inflammation and tissue dysfunction.

Every Radiptide batch is manufactured under strict quality control and tested for identity and purity. Certificate of Analysis (COA) available on request.